Capsaicin

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Capsaicin
Generic name
CAPSAICIN
Manufacturer
PHARMACURE LLC
Product type
HUMAN OTC DRUG
SPL set ID
119bab58-f129-4ff0-8d81-9c6a7b508dd6
SPL ID
3d730baf-1cbb-b38f-e063-6394a90a1bf5
Version
1
Effective date
2025-08-28
Source export date
2026-09-28
Source partition
8
Source file
https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/ae3816359e336a5de4f44607730a3d12ceb61ffa012a132189ceda22541b38ee/drug-label-0008-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 05:54:20
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only . Use only as directed or as directed by a health care professional. Do not use • On wounds, cuts, damaged, or infected skin • On eyes, mouth, genitals, or any other mucous membranes Stop use and ask a physician : If rash, itching, or excessive skin irritation develops. If conditions worsen. If symptoms persist for more than 7 days. If symptoms clear up and occur again within a few days. Keep out of reach of children and pets. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) immediately. Allergy Alert : If you are allergic to capsicum or chili peppers or any inactive ingredient of this product, contact a doctor before use. When using this product You may experience a burning sensation. The intensity of this reaction varies among individuals and may be severe. With regular use, this sensation generally disappears after several days. • Do not apply heat to the treated area immediately before or after use

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.